Results reported for Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis. Company plans to meet with the FDA to ...

Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis Further development of namilumab for the treatment of sarcoidosis will be discontinued BASEL, Switzerland and LONDON ...

Dear Dr. Roach: Our son is 43 and has sarcoidosis. We can't find out much about this disease. Most doctors don't seem to know much, either. Please help. A: Sarcoidosis, or just sarcoid, is a systemic ...

Learn about Interstitial Lung Disease (ILD), its causes, symptoms, diagnosis, and treatment options. Understand how ILD ...